• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

TriVascular

Appeals court denies inventor in patent spat with Endologix pickup TriVascular

November 4, 2016 By Brad Perriello

A federal appeals court yesterday upheld a lower court’s ruling on the claim construction in a patent infringement dispute between the inventor of a vascular stent patent and Endologix (NSDQ:ELGX) acquisition TriVascular Technologies. In February, the U.S. Court of Appeals for the Federal Circuit upheld a Patent Trial & Appeal Board ruling that the patent was not invalid due to obviousness. […]

Filed Under: Legal News, Patent Infringement, Vascular Tagged With: Endologix, TriVascular

Seno Medical grabs ex-CeloNova CFO Davis | Personnel Moves August 12, 2016

August 12, 2016 By Fink Densford

Seno Medical grabs ex-CeloNova CFO Davis Seno Medical Instuments said this week it tapped former CeloNova BioSciences chief financial officer Eric Davis to take over the CFO role at Seno Medical. Prior to his years at CeloNova, Davis operated as CFO and operating officer at Genesis Networks Enterprises. Seno Medical said that Davis has more than […]

Pages: Page 1 Page 2 Page 3 Page 4

Filed Under: Business/Financial News Tagged With: Allergan, CeloNova BioSciences, Cerus Corp., CooperVision, Endologix, InVivo Therapeutics, Medtronic, Personnel Moves, ReVision Optics Inc., Seno Medical Instruments, TriVascular, UnitedHealth Group

TriVascular loses appeal in patent spat with vascular stent inventor

February 8, 2016 By Fink Densford

TriVascular Technologies (NSDQ:TRIV) last Friday lost an appeal in a vascular stent patent spat after a Federal Circuit court upheld a Patent Trial and Appeal Board ruling that found the stent’s patent, held by a separate inventor, was not invalid due to obviousness. The court upheld the ruling on the grounds that TriVascular didn’t demonstrate that the […]

Filed Under: Business/Financial News, Legal News, Stents Tagged With: TriVascular

Endologix, TriVascular Technologies close $211m merger

February 4, 2016 By Brad Perriello

Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) said yesterday that they closed their $221 million merger, uniting 2 of the stent graft market’s smaller players. Both companies makes devices for treating abdominal aortic aneurysms; Irvine, Calif.-based Endologix makes 2 lines of stent grants, the Nellix and AFX devices, while Santa Rosa, Calif.-based TriVascular makes the Ovation stent graft. “The completion […]

Filed Under: Mergers & Acquisitions, Stent Grafts, Wall Street Beat Tagged With: Endologix, TriVascular

Endologix, TriVascular clear U.S. regulatory hurdle in $211m merger

November 19, 2015 By Brad Perriello

Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) yesterday said that the waiting period set by U.S. anti-trust laws for their $211 million merger ended early, setting the stage for the deal to close during the 1st quarter next year. The companies said the U.S. Federal Trade Commission and Justice Dept. granted early termination of the waiting period under […]

Filed Under: Mergers & Acquisitions, Stent Grafts, Wall Street Beat Tagged With: Endologix, TriVascular

VIVA 2015 Roundup: Medtronic touts Valiant stent graft, PAD stent-treatment data

November 6, 2015 By Fink Densford

Medtronic (NYSE:MDT) this week presented data from 2 studies of its stent systems and announced a new study of its In.Pact Admiral drug-coated balloon. The announcements were made at the VIVA physicians annual conference in Las Vegas, Nev. The Fridley, Minn.-based medical giant presented data from a 2-year clinical trial of its Valiant Captivia thoracic stent graft […]

Filed Under: Cardiovascular, Clinical Trials, Vascular Tagged With: Abbott, Avinger, Boston Scientific, C.R. Bard, Cook Medical, Medtronic, Spectranetics Corp., TriVascular, TVA Medical, Vascular Interventional Advances (VIVA), vasculardynamics

Endologix, TriVascular Technologies ink $211m merger

October 27, 2015 By Brad Perriello

Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) yesterday said they plan to merge in a cash-and-stock deal worth $211 million. If consummated, the deal would unite 2 of the stent graft market’s smaller players. Both companies makes devices for treating abdominal aortic aneurysms; Irvine, Calif.-based Endologix makes 2 lines of stent grants, the Nellix and AFX devices, while […]

Filed Under: MassDevice Earnings Roundup, Stent Grafts Tagged With: Endologix, TriVascular

TriVascular Technologies raises $10m, launches study of EVAR in women

August 24, 2015 By Brad Perriello

Trivascular Technologies (NSDQ:TRIV) said it raised a $10 million funding round and launched a clinical study of endovascular aortic repair in women using its Ovation stent graft. Santa Rosa, Calif.-based TriVascular said in a regulatory filing that it raised $10 million from 5 unnamed investors in a debt-and-warrants offering. The company, which won pre-market approval […]

Filed Under: Clinical Trials, Endoscopic, Stent Grafts, Vascular Tagged With: TriVascular

2014: The year of the medtech IPO | Medtech Wall Street news for the week of December 15, 2014

December 18, 2014 By MassDevice

Year in review: 2014 was the year of the medtech IPO

December 10, 2014 by MassDevice staff

Filed Under: News Well, Respiratory, Wall Street Beat Tagged With: Inogen, Johnson and Johnson, K2M, Nevro Corp., oculartherapeutix, Sientra, Symmetry Medical Inc., Symmetry Surgical, Tecomet Inc., TriVascular, Volcano Corp.

Year in review: 2014 was the year of the medtech IPO

December 10, 2014 By MassDevice staff Leave a Comment

Year in review: 2014 was the year of the medtech IPO

Click to enlarge

It was, as predicted, the year of the IPO for medical device companies, with 25 filing initial public offerings during 2014, according to a MassDevice.com analysis.

Filed Under: Initial Public Offering (IPO), News Well, Wall Street Beat Tagged With: 2014, Johnson and Johnson, K2M, Nevro Corp., oculartherapeutix, Sientra, TriVascular, Volcano Corp.

FDA approves TriVascular’s CustomSeal for aortic aneurysms

October 20, 2014 By Alexander Soule Leave a Comment

FDA approves TriVascular's CustomSeal for aortic aneurysms

Filed Under: News Well, Pre-Market Approval (PMA), Stent Grafts Tagged With: TriVascular

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS